最新ニュース Mesabi Tr (NYSE:MSB) 株価情報

Mesabi Tr

Mesabi Trust

Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of the assets held. The company's principally wholly-owned segment is the iron ore mining segment and it generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.

Misbloc

MERCER BANCORP INC by Mercer Bancorp, Inc.

Mercer Bancorp Inc

Mission Bancorp

Mitsubishi Corp

Midland States Bancorp, Inc. - Common Stock

Midland States Bancorp Inc

Midland States Bancorp, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A

MSB GLOBAL CAPITAL CORP by MSB Global Capital Corp.

MSB Global Capital Corp

Messaben Corp

MITSUBISHI PENCIL CO LTD by Mitsubishi Pencil Co Ltd

Mitsubishi Pencil Co Ltd

WIIM

CRML

LITM

PPTA

SBSW

SCCO

STLD

TECK

Shares of metal and mining companies are trading lower amid overall market weakness on US consumer and economic concerns.

Mesabi Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSB#NYSE">MSB</a>):
Receipt of Quarterly Royalty Report and Royalty Payment
On April 30, 2024, the Trustees of Mesabi Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSB#NYSE">MSB</a>) received the quarterly royalty report of iron ore shipments from Silver Bay, Minnesota during the quarter ended March 31, 2024 (the "Royalty Report") from Cleveland-Cliffs Inc. ("Cliffs"), the parent company of Northshore Mining Company ("Northshore").
As reported to Mesabi Trust by Cliffs in the Royalty Report, based on shipments of iron ore products by Northshore during the three months ended March 31, 2024, Mesabi Trust was credited with a base royalty of $2,106,086. For the three months ended March 31, 2024, Mesabi Trust was also credited with a bonus royalty in the amount of$2,520,601. The royalty payment received by the Trust also included an increase of $279,222 as a result of positive adjustments related to prior quarters. In addition, a royalty payment of $153,738 was paid to the Mesabi Land Trust. Accordingly, the total royalty payments received by Mesabi Trust on April 30, 2024 from Cliffs were $5,059,648.
The royalties paid to Mesabi Trust are based on the volume of iron ore pellets and other products produced or shipped during the quarter and the year to date, the pricing of iron ore product sales, and the percentage of iron ore pellet production and shipments from Mesabi Trust lands rather than from non-Mesabi Trust lands. In the first calendar quarter of 2024, Cliffs credited Mesabi Trust with 1,006,692 tons of iron ore shipped, as compared to zero (0) tons shipped during the first calendar quarter of 2023. Cliffs' Royalty Report reflected no additional third party arms-length sale transactions of iron ore pellets since reporting two low volume shipments of iron ore pellets to a single third-party customer in June 2023.
The volume of iron ore pellets (and other iron ore products) produced or shipped by Northshore varies from quarter to quarter and year to year based on a number of factors, including, among others, Cliffs' decisions to idle Northshore operations (which occurred from May 2022 until April 2023), the requested delivery schedules of customers (including affiliates), general economic conditions in the iron ore industry, and production schedules and weather conditions on the Great Lakes. These multiple factors can result in significant variations in royalties received by Mesabi Trust (and in turn, the resulting funds available for distribution to Unitholders by Mesabi Trust) from quarter to quarter and from year to year. These variations, which can be positive or negative, cannot be predicted by the Trustees of Mesabi Trust. Based on the above factors, and as indicated by Mesabi Trust's historical distribution payments, the royalties received by Mesabi Trust, and the distributions paid to Unitholders, if any, in any particular quarter are not necessarily indicative of royalties that will be received, or distributions that will be paid, if any, in any subsequent quarter or full year.
The Trustees of Mesabi Trust have received no specific updates concerning Cliffs' plans with respect to Northshore iron ore operations. The last reported Cliffs' public announcements made in April 2023 included that Northshore was then being partially restarted and would be run at less than full capacity for the remainder of 2023, and that Cliffs would continue to treat Northshore as a swing operation. With respect to calendar year 2024, Northshore has not advised Mesabi Trust of its expected shipments of iron ore products, or what percentage of 2024 shipments will be from Mesabi Trust iron ore.

News

Contracts

Mesabi Trust Says Total Royalty Payments Received On April 30, 2024 From Cliffs Were $5,059,648

CENX

VALE

Shares of several metals & mining companies are trading lower amid reports of weakness in Chinese demand.

Options

ACHV

ACST

AMBP

ANGI

AUDC

AUGX

BAND

BLBX

BLDE

BLND

BNTC

CERT

CMPR

COMS

CVGI

CZOO

DLPN

DTST

ENTX

EQOS

FAZE

FTHM

GSHD

GSIT

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HILS

Invesco High Income 2024 Target Term Fund Common Shares of Beneficial Interest, No par value per share

IHTA

IMMX

INPX

JXJT

LCTX

LIDR

LINC

LITE

LPSN

LSTA

MEDS

MNMD

MOBBW

MVST

NMAI

NPFD

NUWE

Nuveen Insured Dividend Advantage Municipal Fund

NVOS

ONVO

OTLY

PACK

PIXY

PLTK

PRTS

PSNL

RCRT

RDFN

RENT

RLMD

RNLX

SASI

SCOR

SFIX

SLGG

SMIT

SWVL

TDUP

TVTX

UTRS

VAPO

VERO

VVPR

WISH

WLDN

121 Stocks That Hit Their 52-Week Low

Intraday Update

Markets

Movers

Trading Ideas

MBIO

Blackrock Muniyield California Insured Fund

MCLD

Blackrock Muniholdings Investment Quality Fund

MGNX

Blackrock Muniholdings New York Quality Fund

MIND

MITO

MTEM

Blackrock Muni Intermediate Duration Fund Inc

MULN

Blackrock Muniyield New York Quality Fund

Neuberger Berman Intermediate Municipal Fund Inc.

Nuveen Dynamic Municipal Opportunities Fund Common Shares of Beneficial Interest

NDMO

NDRA

Nuveen Insured Tax-Free Advantage Municipal Fund

NERV

NLTX

Nuveen Municipal High Income Opportunity Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NUVB

Nuveen California Dividend Advantage Municipal Fund 2

Nuveen New Jersey Dividend Advantage Municipal Fund

Nuveen Dividend Advantage Municipal Fund 3

OBSV

OLMA

ONCR

OTRK

PBYI

PGEN

PHAS

PRLH

PRQR

PSTX

PYXS

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RAIN

RERE

ROCK

RUBY

RYTM

SBUX

SCPS

SELB

SIOX

SKIL

SPRB

STAB

STIM

STRO

STTK

SYRS

TIVC

Stocks That Hit 52-Week Lows On Monday

<h3>Gainers</h3>
<ul>
<li>Y-mAbs Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymab#NASDAQ">YMAB</a>) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.</li>
<li>China Online Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coe#NYSE">COE</a>) gained 23.3% to settle at $1.59 on Friday.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) jumped 23.1% to settle at $2.24 on Friday. Kaival Brands recently won judicial stay of FDA&#39;s marketing denial order.</li>
<li>InterCure Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/incr#NASDAQ">INCR</a>) surged 21.8% to settle at $8.20. Intercure recently reported preliminary Q4 revenue.</li>
<li>Reservoir Media, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsvr#NASDAQ">RSVR</a>) jumped 21.2% to close at $7.02. The company recently raised its FY22 sales guidance.</li>
<li>LiveOne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lvo#NASDAQ">LVO</a>) gained 21.1% to close at $0.97 after the company reported Q3 earnings results.</li>
<li>Mr. Cooper Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coop#NYSE">COOP</a>) climbed 19.2% to close at $49.22 following upbeat quarterly earnings.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) surged 18.9% to settle at $8.51.</li>
<li>Aziyo Biologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azyo#NASDAQ">AZYO</a>) gained 18.7% to close at $6.41.</li>
<li>Sundial Growers Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) surged 18.5% to settle at $0.6629. Sundial Growers recently announced that it has received an extension of 180 calendar days to regain compliance with Nasdaq&#39;s minimum bid price requirement.</li>
<li>OceanPal Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/op#NASDAQ">OP</a>) gained 17.2% to close at $0.4979. OceanPal entered into a time charter contract with Crystal Sea Shipping Co., Limited for its Panamax dry bulk vessel, the m/v Calipso.</li>
<li>Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) climbed 16.7% to close at $38.73. JPMorgan upgraded Carpenter Technology to Overweight from Neutral and raised the price target to $53 (an upside of 59.5%) from $52.</li>
<li>MOGU Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mogu#NYSE">MOGU</a>) jumped 16.7% to close at $0.3747.</li>
<li>Vision Marine Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmar#NASDAQ">VMAR</a>) gained 16.2% to close at $5.32. Vision Marine Technologies signed a joint development agreement with Weismann Marine LLC to design and develop a lower unit assembly for its E-Motion 180 HP outboard propulsion system.</li>
<li>Houston American Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/husa#NYSE">HUSA</a>) jumped 15.9% to settle at $1.31.</li>
<li>Vimeo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmeo#NASDAQ">VMEO</a>) rose 15.2% to close at $12.95. Vimeo recently reported Q4 earnings results.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) jumped 15.2% to close at $5.85.</li>
<li>Modular Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/modd#NASDAQ">MODD</a>) shares gained 14.8% to close at $4.26 on Friday following its recent uplisting to the Nasdaq Capital Market on Thursday.</li>
<li>Gran Tierra Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gte#NYSE">GTE</a>) jumped 14.6% to close at $1.26.</li>
<li>NGL Energy Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngl#NYSE">NGL</a>) rose 14.1% to close at $2.19. NGL Energy Partners recently reported Q3 earnings results.</li>
<li>IonQ, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NASDAQ">IONQ</a>) surged 14% to close at $16.82.</li>
<li>Peabody Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/btu#NYSE">BTU</a>) gained 13.9% to settle at $17.02. The company, last week, reported upbeat quarterly results.</li>
<li>LSB Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lxu#NYSE">LXU</a>) climbed 13.2% to close at $12.67.</li>
<li>Zillow Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zg#NASDAQ">ZG</a>) gained 12.7% to close at $53.92 after the company reported better-than-expected Q4 sales results.</li>
<li>Patterson-UTI Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pten#NASDAQ">PTEN</a>) jumped 11.8% to settle at $12.74.</li>
<li>Newell Brands Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nwl#NYSE">NWL</a>) gained 11.1% to close at $24.39 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 sales guidance above analyst estimates.</li>
<li>InnovAge Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/innv#NASDAQ">INNV</a>) climbed 10% to close at $5.01. InnovAge recently reported worse-than-expected Q2 EPS results.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) climbed 9% to settle at $16.88 after the company reported better-than-expected Q4 sales results.</li>
<li>XPEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpel#NASDAQ">XPEL</a>) rose 8.7% to close at $62.95 after it was announced the company will replace PDC Energy in the S&amp;P SmallCap 600.</li>
<li>GoDaddy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gddy#NYSE">GDDY</a>) jumped 8.6% to close at $80.60 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 and announced a $3 billion share buyback.</li>
<li>Orphazyme A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orph#NASDAQ">ORPH</a>) gained 8.3% to close at $2.21 as the company issued an update for planned NDA resubmission for arimoclomol for the treatment of Niemann-Pick disease type C in the United States.</li>
<li>Proto Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prlb#NYSE">PRLB</a>) gained 5.3% to close at $56.34 after the company reported better-than-expected Q4 adjusted EPS and sales results.</li>
<li>Yelp Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yelp#NYSE">YELP</a>) gained 4.1% to close at $35.93 after the company reported better-than-expected Q4 EPS and sales results and issued FY22 net sales guidance.</li>
</ul>

<a href="https://www.benzinga.com/news/22/02/25564366/executives-sell-around-44m-of-5-stocks">Executives Sell Around $44M Of 5 Stocks</a>
<h3>Losers</h3>
<ul>
<li>ProQR Therapeutics N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prqr#NASDAQ">PRQR</a>) shares dipped 75.4% to close at $1.39 on Friday after the company reported the study did not meet the primary endpoint, nor notable secondary endpoints in the Phase 2/3 Illuminate trial for seporfarsen.</li>
<li>Enveric Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) shares dropped 49% to settle at $0.3366 after the company priced 20 million share common stock offering at $0.50 per share.</li>
<li>Surgalign Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srga#NASDAQ">SRGA</a>) shares dropped 45.6% to close at $0.3241 after the company reported pricing of $20 million public offering.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) fell 45.4% to close at $3.00 as the company priced its IPO at $5.50 per unit.</li>
<li>Quanergy Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qngy#NYSE">QNGY</a>) fell 41.4% to close at $3.02.</li>
<li>Betterware de Mexico, S.A.B. de C.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwmx#NASDAQ">BWMX</a>) declined 34.3% to close at $13.96 after the company reported Q4 results.</li>
<li>Senseonics Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sens#NYSE">SENS</a>) fell 33.7% to close at $2.42 after the company issued FY22 net sales guidance below estimates.</li>
<li>Mesabi Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msb#NYSE">MSB</a>) fell 27.5% to close at $22.18.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gt#NASDAQ">GT</a>) dropped 27.4% to settle at $15.77. The company reported better-than-expected Q4 EPS and sales results.</li>
<li>Universal Insurance Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uve#NYSE">UVE</a>) fell 27.3% to close at $12.43. Universal Insurance Holdings is expected to release Q4 results after the close of trading on the NYSE on Thursday, February 24, 2022.</li>
<li>Horizon Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzn#NYSE">HZN</a>) dropped 27% to close at $5.11 after the company issued soft preliminary Q4 sales guidance.</li>
<li>Hudson Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/husn#NASDAQ">HUSN</a>) shares fell 23.4% to close at $2.28 after jumping around 25% on Thursday. Hudson Capital merger partner Freigght App sees FY22 sales to be no less than $40 million.</li>
<li>Tritium DCFC Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcfc#NASDAQ">DCFC</a>) dipped 23.2% to close at $10.24.</li>
<li>Sonic Foundry, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofo#NASDAQ">SOFO</a>) fell 22.8% to close at $3.02.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) dropped 22.5% to close at $1.34.</li>
<li>IAA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iaa#NYSE">IAA</a>) dipped 22.2% to close at $35.67 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Confluent, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cflt#NASDAQ">CFLT</a>) fell 21.9% to close at $57.18 after the company reported Q4 earnings results.</li>
<li>EQRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqrx#NASDAQ">EQRX</a>) dipped 21.6% to settle at $3.26.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares fell 20.7% to close at $46.55. Affirm reported worse-than-expected Q2 EPS results.</li>
<li>cbdMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ycbd#NASDAQ">YCBD</a>) fell 19.5% to close at $0.7891 after the company reported Q1 sales results were lower year over year.</li>
<li>Clever Leaves Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clvr#NASDAQ">CLVR</a>) dropped 19.2% to close at $1.60.</li>
<li>Byrna Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/byrn#NASDAQ">BYRN</a>) fell 18.9% to settle at $8.57 after the company reported worse-than-expected Q4 EPS results and cut its Q1 and FY22 sales guidance below analyst estimates.</li>
<li>LightPath Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpth#NASDAQ">LPTH</a>) fell 18.2% to close at $2.11 following weak quarterly results.</li>
<li>Greenwich LifeSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glsi#NASDAQ">GLSI</a>) dipped 18.2% to settle at $19.87.</li>
<li>Fast Radius, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fsrd#NASDAQ">FSRD</a>) fell 18.1% to settle at $3.72.</li>
<li>Freshworks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frsh#NASDAQ">FRSH</a>) fell 18% to close at $18.41 after the company reported Q4 earnings results.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) dipped 17.5% to close at $0.7130 after the company reported worse-than-expected Q2 EPS results.</li>
<li>Maris-Tech Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtek#NASDAQ">MTEK</a>) dropped 16.7% to close at $1.80.</li>
<li>Heartcore Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htcr#NASDAQ">HTCR</a>) shares fell 16.6% to close at $4.13. The company, on Thursday, priced its IPO at $5 per share.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) fell 16.2% to settle at $2.90.</li>
<li>Inotiv, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/notv#NASDAQ">NOTV</a>) dropped 16% to close at $32.33 after the company reported Q1 earnings results.</li>
<li>BlackLine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bl#NASDAQ">BL</a>) dropped 15.8% to close at $76.73 following weak quarterly earnings.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) dropped 15.4% to settle at $30.00 following downbeat quarterly earnings.</li>
<li>Insperity, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nsp#NYSE">NSP</a>) dropped 15.2% to close at $91.95 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apdn#NASDAQ">APDN</a>) fell 15.1% to close at $2.64 after the company reported worse-than-expected Q1 EPS results.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) declined 15.1% to close at $3.32 after the company reported it experienced an issue with a flight that resulted in payloads not being delivered to orbit.</li>
<li>Nymox Pharmaceutical Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nymx#NASDAQ">NYMX</a>) dropped 15% to close at $1.42.</li>
<li>BARK, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bark#NYSE">BARK</a>) fell 14.8% to close at $3.46 after the company reported Q3 earnings results.</li>
<li>Qualys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qlys#NASDAQ">QLYS</a>) fell 14.4% to settle at $115.36 after the company issued FY21 EPS guidance below estimates.</li>
<li>Cian PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cian#NYSE">CIAN</a>) dipped 13.9% to close at $8.17.</li>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) fell 12.6% to close at $2.29.</li>
<li>Under Armour, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uaa#NYSE">UAA</a>) dipped 12.5% to close at $17.51 following Q4 results.</li>
<li>PetVivo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/petv#NASDAQ">PETV</a>) shares fell 12.4% to close at $1.3450 after the company reported worse-than-expected Q3 EPS results.</li>
<li>IronNet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irnt#NASDAQ">IRNT</a>) fell 12% to settle at $3.80. IronNet shares jumped 23% on Thursday after the company announced an agreement with a Gulf Cooperation Council country to provide collective defense for critical national infrastructure.</li>
<li>Mersana Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrsn#NASDAQ">MRSN</a>) dropped 10.4% to settle at $4.32.</li>
</ul>
Also check out this: <a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25562596/hanesbrands-and-2-other-stocks-bought-by-insiders"> Hanesbrands And 2 Other Stocks Bought By Insiders </a>

Comments

Mesabi Tr

ニュース

最新ニュース Mesabi Tr (NYSE:MSB) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル